DULOXETINE
Live / Applied — Statement of use — processing complete, to examiner (as of 16 Nov 2026)
What this means for you
Not registered yet, but its 05 Nov 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99480548
- Mark type
- Stylized text
- Kind
- Trademark
- Register
- Principal
- Basis
- Intent to use (§1(b))
- Filed
- 05 Nov 2025
- Published for opposition
- 15 Sept 2026
- Examining attorney
- Natalie Elizaroff
- Attorney of record
- Gregg A. Paradise
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders
Owner
- Almatica Pharma LLC, Morristown, NJ, US
- Almatica Pharma LLC, Morristown, NJ, US
Prosecution history
- 16 Nov 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Nov 2026 — USE AMENDMENT FILED
- 16 Nov 2026 — TEAS STATEMENT OF USE RECEIVED
- 10 Nov 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Sept 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Sept 2026 — PUBLISHED FOR OPPOSITION
- 09 Sept 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Aug 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Aug 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 17 Aug 2026 — EXAMINER'S AMENDMENT ENTERED
- 17 Aug 2026 — EXAMINERS AMENDMENT E-MAILED
- 17 Aug 2026 — EXAMINERS AMENDMENT -WRITTEN
- 15 Jul 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Jul 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Jul 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED